TERF2 and hepatocellular carcinoma: TERF2 has been found to be overexpressed in colorectal carcinoma [8], breast cancer [25], gastric cancer [6,13], glioblastoma [26], head and neck squamous cell carcinoma [27], hepatocellular carcinoma [10,28,29], acute myeloid leukemia [12], lung cancer [22], renal cell carcinoma [30], skin cancer [31] and oral squamous cell carcinoma [14].